Three Horizons Framework
for Manufacture of starches and starch products (ISIC 1062)
The starch and starch products industry is an excellent fit for the Three Horizons Framework due to its dual nature: a mature core business in commodity starches and a burgeoning need for innovation in specialty derivatives and future bio-based materials. The industry's high R&D burden (IN05), risk...
Short, medium, and long-term strategic priorities
Optimize efficiency, reduce costs, and stabilize core high-volume commodity starch production to protect existing margins against raw material volatility and mature market pressures.
- Implement advanced process digitization and automation in core corn wet milling and tapioca starch extraction plants to enhance yield and reduce energy consumption.
- Deploy real-time raw material price hedging strategies (e.g., futures contracts for corn, wheat) to mitigate short-term price volatility (FR01, FR07).
- Introduce predictive maintenance programs for key processing equipment (e.g., centrifuges, dryers) to minimize downtime and improve operational throughput.
- Standardize and optimize logistics and distribution channels for bulk commodity starches to reduce transportation costs (MD06).
Develop and commercialize a pipeline of high-value specialty starch derivatives and adjacent bio-based solutions to diversify revenue streams, combat market obsolescence (MD01), and capture higher-margin growth opportunities.
- Establish dedicated innovation hubs focusing on advanced modification technologies for food starches (e.g., clean label starches, resistant starches) and industrial applications (e.g., bio-adhesives, textile sizings).
- Form strategic R&D partnerships with consumer goods companies and material science firms to co-develop customized starch-based ingredients for specific functional requirements.
- Invest in pilot-scale production facilities for novel starch-based bioplastics or biodegradable packaging components.
- Expand geographical market penetration for existing specialty starches, leveraging regional demand for specific applications (MD02).
Invest in disruptive bio-innovations and explore radically new feedstocks and production technologies to ensure long-term supply chain resilience, redefine the industry, and address fundamental raw material and sustainability challenges.
- Fund a strategic ventures arm to invest in startups and academic research focusing on microbial starch production, cell-free starch synthesis, or starch from non-traditional biomass sources (e.g., algae, agricultural waste).
- Initiate R&D programs for advanced biorefining concepts that extract multiple high-value co-products (e.g., proteins, fibers) from starch feedstocks, beyond traditional co-products.
- Establish long-term research collaborations with genetic engineering firms to develop next-generation starch-rich crops with enhanced yield, stress resistance, and customized starch profiles (IN01).
- Pilot projects exploring the commercial viability of closed-loop starch production systems, potentially integrating carbon capture or waste valorization technologies.
Strategic Overview
The 'Manufacture of starches and starch products' industry (ISIC 1062) operates within a dynamic environment characterized by mature, high-volume commodity products alongside rapidly evolving specialty applications. The industry faces significant challenges including market obsolescence risk from alternative ingredients (MD01), substantial R&D investment burden (IN05), and volatility in raw material prices (FR01, IN01). Balancing the optimization of existing revenue streams with the pursuit of future growth opportunities is critical for long-term sustainability and competitiveness. The Three Horizons Framework offers a structured approach to manage innovation and growth across these different timeframes. By categorizing initiatives into Horizon 1 (optimizing the core business), Horizon 2 (building emerging opportunities), and Horizon 3 (creating genuinely new options), the framework enables strategic resource allocation. This systematic approach helps mitigate risks associated with high capital expenditure (MD07, IN02) and market saturation (MD08) by fostering a culture of continuous innovation and strategic foresight, ensuring the industry can adapt to future demands and disruptions. For ISIC 1062, applying this framework allows companies to defend their position in traditional markets through efficiency gains, while simultaneously investing in high-growth specialty segments like bioplastics or functional food ingredients, and exploring disruptive technologies such as cellular agriculture or advanced biorefining. This balanced portfolio approach is essential for navigating the complex interplay of commodity pressures and the imperative for high-value innovation.
5 strategic insights for this industry
Dual Nature of Starch Market Requires Differentiated Investment
The industry is split between high-volume, low-margin commodity starches (e.g., native corn starch, glucose syrups) and high-value, low-volume specialty starches (e.g., modified starches for pharmaceuticals, bioplastics). Horizon 1 efforts must focus on cost leadership and operational efficiency for the former, while Horizon 2 and 3 should concentrate on R&D-intensive differentiation and new market creation for the latter, addressing MD08 (Structural Market Saturation) and MD07 (Structural Competitive Regime).
Raw Material Volatility and Supply Chain Resilience Drives H3 Exploration
High biological improvement & genetic volatility (IN01) and price volatility (FR01) of agricultural raw materials (corn, wheat, tapioca) make long-term exploration (H3) into alternative feedstocks, circular economy models, or advanced biorefining technologies crucial for future supply chain stability and reduced input risk.
Significant R&D Investment and Market Adoption Challenges for H2/H3
The industry faces a high R&D burden (IN05) and substantial capital requirements for new product development and plant modernization (IN02, MD07). H2/H3 innovations, such as novel starch derivatives for bioplastics or cellular agriculture inputs, require not only significant upfront investment but also careful market development and adoption strategies to overcome MD01 (Market Obsolescence & Substitution Risk) and ensure commercial viability.
Policy and Regulatory Landscape Influences H2/H3 Trajectories
Development programs and policy dependency (IN04), particularly around sustainability, bio-based products, and food security, can significantly impact the viability and acceleration of H2 (e.g., sustainable packaging starch) and H3 (e.g., novel bio-refinery processes) initiatives. Proactive engagement with policy makers can mitigate risks and unlock funding.
Risk of Market Obsolescence Requires Proactive Portfolio Diversification
The constant threat of substitution from alternative ingredients, synthetic compounds, or evolving consumer preferences (MD01) necessitates a continuous pipeline of H2 and H3 innovations. Companies must diversify their product portfolio beyond traditional starches to maintain market relevance and open new revenue streams, leveraging their innovation option value (IN03).
Prioritized actions for this industry
Horizon 1: Implement Advanced Process Digitization and Automation for Core Products
To maintain cost competitiveness and improve efficiency in the mature commodity starch segment, invest in AI/ML-driven process optimization, predictive maintenance, and energy management systems. This directly addresses high operational costs (LI09), legacy drag (IN02), and margin compression (MD07).
Horizon 2: Establish Dedicated Innovation Hubs for Specialty Starch Derivatives
Create focused R&D and business development units for high-value starch derivatives targeting specific industrial sectors (e.g., bioplastics, pharmaceuticals, specialized food textures). This accelerates time-to-market for new products, combats market saturation (MD08), and leverages innovation option value (IN03).
Horizon 3: Fund a Strategic Ventures Arm for Disruptive Bio-Innovations
Allocate a portion of R&D budget to explore truly disruptive, long-term opportunities such as cellular agriculture inputs, novel microbial starch synthesis, or advanced biorefineries utilizing waste streams. This pre-empts market obsolescence (MD01), diversifies raw material risk (IN01), and positions the company as a future leader in the bioeconomy.
Develop a Robust Intellectual Property (IP) Strategy Across All Horizons
Proactively secure patents, trademarks, and trade secrets for H1 process improvements, H2 product innovations, and H3 technological breakthroughs. This protects significant R&D investments (IN05) and creates sustainable competitive advantages, especially against new entrants and alternative ingredients (MD01).
Foster External Collaboration and Open Innovation for H2/H3 initiatives
Partner with universities, startups, and research institutes for H2 product development and H3 fundamental research. This reduces the internal R&D burden (IN05), accesses specialized expertise, and mitigates the risk of high capital investment (IN02) by sharing costs and leveraging external innovation option value (IN03).
From quick wins to long-term transformation
- Conduct a strategic portfolio review to classify existing products and ongoing projects into the three horizons.
- Identify and prioritize 2-3 immediate H1 process optimization projects with clear ROI (e.g., energy efficiency improvements).
- Allocate a small 'exploration budget' for initial H3 research or startup scouting.
- Launch 1-2 new high-value starch derivatives (H2) based on identified market needs and secure initial customer contracts.
- Establish cross-functional teams for H2 and H3 initiatives with clear mandates and dedicated resources.
- Develop formal stage-gate processes for managing projects across horizons, including clear 'kill points' for underperforming initiatives.
- Integrate the Three Horizons framework into the annual strategic planning and budgeting cycles.
- Develop a corporate venture capital arm or strategic partnership program to invest in H3 technologies.
- Cultivate an organizational culture that embraces experimentation, learning from failure, and strategic foresight.
- Under-resourcing or de-prioritizing H2 and H3 initiatives due to short-term H1 pressures.
- Lack of clear distinction between the horizons, leading to H1 metrics being applied to H2/H3 projects.
- Failure to effectively 'kill' projects in H2 or H3 that are not gaining traction, leading to resource drain.
- Organizational resistance to change and fear of cannibalizing existing products with new innovations.
- Inadequate leadership sponsorship and communication across the organization regarding the framework's purpose.
Measuring strategic progress
| Metric | Description | Target Benchmark |
|---|---|---|
| H1: Operational Efficiency Improvement (%) | Percentage reduction in energy consumption, waste generation, or cost per ton of starch produced in core operations. | 3-5% annual improvement |
| H2: Revenue from New Products (%) | Percentage of total revenue derived from products launched in the last 3-5 years (representing H2 innovations). | 10-15% within 5 years |
| H2: R&D Investment in Specialty Starch Development (USD/EUR) | Absolute or percentage of total R&D budget specifically allocated to developing new specialty starch derivatives. | 2-3% of total revenue annually |
| H3: Number of Strategic Ventures/Partnerships | Count of pilot projects, academic collaborations, or venture investments in disruptive starch-related technologies. | 2-3 active H3 initiatives |
| Overall: Innovation Pipeline Value | Estimated future revenue potential or market share gains from products and technologies currently in H2/H3 development. | Quantifiable long-term value |
Other strategy analyses for Manufacture of starches and starch products
Also see: Three Horizons Framework Framework